biointellisense.comHealthcare / Digital HealthFounded: 2018Funding to Date: $260.65MM
BioIntelliSense is a provider of continuous health monitoring and clinical intelligence solutions for Remote Patient Monitoring (RPM) and developer of a medical-grade Data-as-a-Service (DaaS) platform designed to seamlessly capturesminute-to-minute vital signs, physiological biometrics and symptomatic events through an effortless patient experience.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/15/2022 | Series B-1-1 | $10.37MM | $xx.xx | $1.18B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
341,500
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/15/2022 | Series B-1 | $168.3MM | $xx.xx | $1.18B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,434,782
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/28/2021 | Series B | $44.99MM | $xx.xx | $1.08B | 7wire Technology Partners, Chimera, Fresenius Medical Care North America, James Murren, Mary Tolan, Pendrell Corporation, Royal Philips | |
Price per Share
$xx.xx
Shares Outstanding
1,185,398
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Technology Partners, Chimera, Fresenius Medical Care North America, James Murren, Mary Tolan, Pendrell Corporation, Royal Philips
|
||||||
09/10/2020 | Series A-1 | $12MM | $xx.xx | $107.68MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,540,939
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/09/2019 | Series A | $25MM | $xx.xx | $62.49MM | Cu Healthcare Innovation Fund, Tripletree Holdings, Uchealth | |
Price per Share
$xx.xx
Shares Outstanding
9,999,066
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cu Healthcare Innovation Fund, Tripletree Holdings, Uchealth
|